Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy
Key facts
- Who runs it
- Loma Linda University
- Where
- Loma Linda, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 46 people enrolled
- Started
- 1 Aug 2023
- Ended
- 20 May 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Intraneural Facilitation® Therapy (INF® Therapy)
- INF® Therapy
- Record updated
- 14 August 2025
Who can take part
- Age
- 50 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Participants in this study must be/have:
- Older adults between 50 to 75 years of age
- Willing to actively improve neuropathy symptoms
- Diagnosed with Type II diabetes
- Moderate to severe DPN (diabetic peripheral neuropathy) with symptoms below the knees of numbness, tingling, burning, sharp pain, and/or increased sensitivity
- Distal Symmetric Polyneuropathy (DSPN) form of DPN
- Independent in daily activities
- Do not use any assistive device for walking such as a cane, walker, or wheelchair
Who cannot take part
- Current regimen of chemotherapy, radiation, or dialysis
- Documented active drug and/or alcohol misuse
- Known allergy to chrome, nickel, or cobalt; Any of the following medical conditions:
- End stage renal failure
- End stage congestive heart failure
- Uncontrolled hypertension
- Chronic liver disease
- Advanced chronic obstructive pulmonary disease
- Other types of neuropathies not associated with diabetes including B12 deficiency
- Any other chronic medical conditions requiring active treatment
- Currently consuming a mainly plant-based or gluten-free diet
- Lower extremity amputations and open wounds
- Active inflammations
- Morbid obesity
- Pregnancy (self-reported)
Where in United States
- Loma Linda University HealthLoma Linda, United States
About the trial
What the trial wants to find out
The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy called distal symmetric polyneuropathy (DSPN).
The 2 groups in the trial
- Intraneural Facilitation® Therapy (INF® Therapy) + Dietary EducationTreatment being tested
The INF® Therapy+ group will receive dietary education with weekly follow-up by a physical therapist either in person, or via email or text message. The INF® Therapy+ group will additionally receive meal preparation ideas and sample menus promoting a gluten-free diet.
Treatment: Intraneural Facilitation® Therapy (INF® Therapy)
- Intraneural Facilitation® Therapy (INF® Therapy)Existing treatment, for comparison
INF® Therapy is a manual therapy technique that consists of three components. The first is the pressurization or facilitation hold which biases circulation more consistently in the nerves, which is thought to "pressurize the entire system" The secondary hold attempts to stretch the innervated structure, pulling apart the tough dividing membrane and allowing the pressurized blood flow to transport from the outside "holding" chamber to the endoneurium and push open the closed capillary beds next to the nerve axons. Once capillaries surrounding the nerves are pressurized, the circulation needs to be induced up the neural connective tissue. A separate set of pressure points or "holds" are performed distal to the secondary holds to ensure the circulation is drawn up the inflamed capillary beds using the Bernoulli principle.
Treatment: INF® Therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 August 2025